Insight Molecular Diagnostics Inc. Financial and Nonfinancial Liabilities, Fair Value Disclosure
Insight Molecular Diagnostics Inc. (IMDX) had Financial and Nonfinancial Liabilities, Fair Value Disclosure of $39.90 million as of 2023-12-31, per its 10-K filed 2024-04-16.
Discontinued › Notes › Fair Value, Net Asset (Liability)
us-gaap:LiabilitiesFairValueDisclosure · last filed 2024-04-16
- 2023-12-31: Financial and Nonfinancial Liabilities, Fair Value Disclosure $39.90M.
- 2023-09-30: Financial and Nonfinancial Liabilities, Fair Value Disclosure $28.71M.
- 2023-06-30: Financial and Nonfinancial Liabilities, Fair Value Disclosure $29.15M.
- 2023-03-31: Financial and Nonfinancial Liabilities, Fair Value Disclosure $27.36M.
| Period end | Financial and Nonfinancial Liabilities, Fair Value Disclosure |
|---|---|
| 2023-12-31 | $39.90M 10-K · filed 2024-04-16 |
| 2023-09-30 | $28.71M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $29.15M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $27.36M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $45.66M 10-K · filed 2024-04-16 |
| 2022-09-30 | $59.52M 10-Q · filed 2022-11-10 |
| 2021-12-31 | $76.68M 10-K · filed 2023-04-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |